Sunday 15 September
The Evolution of HR+/HER2− Early Breast Cancer Clinical Practice: Broadening the Impact of CDK4/6 Inhibitors
Sunday, 13:00 - 14:30
View the satellite invitation
Staying at the Forefront of HER2- And TROP2-Directed Antibody-Drug Conjugate (ADC) Advances in Breast Cancer
Sunday, 13:00 - 14:30
View the satellite invitation
Tools to Guide Treatment Decisions in Early Breast Cancer: Genomic Testing and Emerging Role Of MRD
Sunday, 18:30 - 20:00
View the satellite invitation
Monday 16 September
How Can We PI3K the Right Treatment for Every Patient With HR+ Breast Cancer?
Monday, 13:00 - 14:30
View the satellite invitation
Advancing Cancer Care: Immunotherapy in Early Stage Cancers
Monday, 13:00 - 14:30
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.